In a study by Zhang et al., it was noted that increased expression of CASC11 in CRC was associated with tumor size, serum infiltration, lymphatic metastasis, and tumor node metastasis (TNM) stage, and it was also noted in their study that CASC11 interacted with hnRNP-K to activate the WNT/beta-catenin pathway, which promotes CRC growth and metastasis [20]. Here, HNRNPK is linked to neoplasm.